Markets:

Overview

News

Currencies

International

Treasuries

CVS Health Corp (NY:CVS)

78.60 -2.76 (-3.39%)

Official Closing Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

64 65 Next >

Gilead Sciences, Upstart, Mercury General, Confluent And Other Big Stocks Moving Higher On Wednesday ↗

February 12, 2025

Via Benzinga

Discover the top S&P500 movers in Wednesday's pre-market session. ↗

February 12, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

CVS Health Q4 Earnings: Revenue And EPS Beat, Same-store Prescription Volume Up 5.9%, Upbeat FY25 Outlook And More ↗

February 12, 2025

CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance set at $5.75-$6.00.

Via Benzinga

CVS Health Surges Premarket As Q4 Earnings Blow Past Estimates, Retail Buzz Builds ↗

February 12, 2025

The company said it continues to see growth in Pharmacy and Consumer Wellness while working to address challenges in its Health Care Benefits segment.

Via Stocktwits

Earnings Scheduled For February 12, 2025 ↗

February 12, 2025

Via Benzinga

What's a Fair Price for CVS Stock? ↗

February 11, 2025

Via The Motley Fool

Peering Into CVS Health's Recent Short Interest ↗

February 10, 2025

Via Benzinga

Is CVS Health's Dividend Safe? ↗

February 07, 2025

Via The Motley Fool

CVS Health’s (NYSE:CVS) Q4 Sales Top Estimates, Stock Soars

February 12, 2025

Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q4 CY2024, with sales up 4.2% year on year to $97.71 billion. Its non-GAAP profit of $1.19 per share was...

Via StockStory

US Stocks Set For A Cautious Start Ahead Of Inflation Data: Expert Says 'Strong Bull Markets Tend To Roar Back To Life After Corrections' ↗

February 12, 2025

U.S. stock futures fell on Wednesday after a mixed close on Tuesday as Federal Reserve Chairman Jerome Powell Congress testimony.

Via Benzinga

Topics Economy

Dow Gains Over 100 Points Following Powell Comments: Fear & Greed Index Remains In 'Neutral' Zone ↗

February 12, 2025

Via Benzinga

Topics Stocks

CVS Health, Kraft Heinz And 3 Stocks To Watch Heading Into Wednesday ↗

February 12, 2025

Via Benzinga

This House of Representative Just Sold Up To $50K In CVS Health Stock ↗

February 05, 2025

Via Benzinga

Should You Buy CVS Health Stock Before Feb. 12? ↗

January 29, 2025

Via The Motley Fool

CVS Health Stock Is Relatively Cheap, Analyst Highlights Cost Trend Pressure Ahead Of Q4 Earnings ↗

February 11, 2025

CVS Health reports Q4 earnings on Feb. 12, with analysts watching cost trends, Medicare Advantage enrollment, and medical loss ratio impacts.

Via Benzinga

CVS Stock Approaches Q4 Earnings With Resistance In Sight ↗

February 11, 2025

CVS Health (CVS) reports Q4 earnings on Wed. Stock is down 29.78% in past yr, up 22.72% YTD. Bullish trend but mixed signals. Analysts rate it a Buy with avg price tgt $63.67, potential 17.01% upside....

Via Benzinga

CVS Health (CVS) Q4 Earnings Report Preview: What To Look For

February 11, 2025

Diversified healthcare company CVS Health (NYSE:CVS) will be announcing earnings results tomorrow morning. Here’s what investors should know.

Via StockStory

Billionaire Money Managers Are Piling Into 3 High-Yield Dividend Stocks Amid a Historically Pricey Stock Market ↗

February 05, 2025

Value-focused billionaire asset managers are trading out pricey stocks for perceived-to-be safe, income-producing, brand-name businesses.

Via The Motley Fool

Cigna Misses EPS: What It Means for the Health Insurance Industry

February 04, 2025

Cigna is one of the most efficiently managed health insurance companies evidenced by its foresight to sell its Medicare Advantage business before the fallout.

Via MarketBeat

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ↗

February 04, 2025

Via Benzinga

Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now

February 03, 2025

Teva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp?

Via MarketBeat

CVS Health Stock Price Is Recovering: Feb 12 Will Be Crucial ↗

January 30, 2025

CVS Health share price has rebounded by 33% from its lowest point in December. The company will publish its fourth-quarter results on February 12. Technicals point to more CVS Health stock surge in the...

Via Talk Markets

Topics Stocks / Equities

RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders ↗

January 29, 2025

Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the American people.

Via Benzinga

Topics Government

9 Health Care Stocks With Whale Alerts In Today's Session ↗

January 28, 2025

Via Benzinga

Momentum Grows for These 3 Healthcare Stocks

January 28, 2025

As the market starts to reflect on the potential tail risks in the S&P 500, a rotation has shown itself in three stocks in the healthcare sector.

Via MarketBeat

Topics Stocks

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 27, 2025

Via Benzinga

CVS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS

January 24, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Walgreens Boots Alliance vs. CVS Health: What's the Better Turnaround Play? ↗

January 24, 2025

Via The Motley Fool

Walgreens Reverses 40% Sprint As DOJ Slams Opioid Prescriptions ↗

January 21, 2025

The retail pharmacy says there are now clear rules for reporting suspicious prescribers.

Via Investor's Business Daily

3 No-Brainer Dividend Stocks to Buy in 2025 ↗

January 19, 2025

Via The Motley Fool

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

64 65 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.